The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Research Report 2025
Synopsis
Genetically engineered human proteins play a crucial role in the market for therapeutic drugs. Therapeutic proteins are essential for maintaining a healthy lifestyle and alleviating chronic disease. They are necessary for people whose bodies cannot produce or break down certain essential proteins naturally. Protein therapy plays an important role in the treatment of various cardiovascular diseases, such as heart failure, myocardial infarction, arrhythmia, coronary artery disease and ischemic heart disease.
The global Therapeutic Proteins for Cardiovascular Disorders Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Proteins for Cardiovascular Disorders Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Proteins for Cardiovascular Disorders Treatment.
Report Scope
The Therapeutic Proteins for Cardiovascular Disorders Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Proteins for Cardiovascular Disorders Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Proteins for Cardiovascular Disorders Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Eli Lilly & Company
Roche
Pfizer
Bristol Myers Squibb
Sanofi
Merck
Amgen
Novartis
Siemens Healthineers
Segment by Type
Monoclonal Antibodies Proteins
Peptides Proteins
Peptide Fragments Proteins
Segment by Application
Heart Failure
Myocardial Infarction
Arrhythmias
Coronary Artery Disease
Ischemic Heart Disease
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Proteins for Cardiovascular Disorders Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Proteins for Cardiovascular Disorders Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Genetically engineered human proteins play a crucial role in the market for therapeutic drugs. Therapeutic proteins are essential for maintaining a healthy lifestyle and alleviating chronic disease. They are necessary for people whose bodies cannot produce or break down certain essential proteins naturally. Protein therapy plays an important role in the treatment of various cardiovascular diseases, such as heart failure, myocardial infarction, arrhythmia, coronary artery disease and ischemic heart disease.
The global Therapeutic Proteins for Cardiovascular Disorders Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Proteins for Cardiovascular Disorders Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Proteins for Cardiovascular Disorders Treatment.
Report Scope
The Therapeutic Proteins for Cardiovascular Disorders Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Proteins for Cardiovascular Disorders Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Proteins for Cardiovascular Disorders Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Eli Lilly & Company
Roche
Pfizer
Bristol Myers Squibb
Sanofi
Merck
Amgen
Novartis
Siemens Healthineers
Segment by Type
Monoclonal Antibodies Proteins
Peptides Proteins
Peptide Fragments Proteins
Segment by Application
Heart Failure
Myocardial Infarction
Arrhythmias
Coronary Artery Disease
Ischemic Heart Disease
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Proteins for Cardiovascular Disorders Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Proteins for Cardiovascular Disorders Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Therapeutic Proteins for Cardiovascular Disorders Treatment Market Overview
1.1 Product Overview and Scope of Therapeutic Proteins for Cardiovascular Disorders Treatment
1.2 Therapeutic Proteins for Cardiovascular Disorders Treatment Segment by Type
1.2.1 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibodies Proteins
1.2.3 Peptides Proteins
1.2.4 Peptide Fragments Proteins
1.3 Therapeutic Proteins for Cardiovascular Disorders Treatment Segment by Application
1.3.1 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Value by Application: (2024-2030)
1.3.2 Heart Failure
1.3.3 Myocardial Infarction
1.3.4 Arrhythmias
1.3.5 Coronary Artery Disease
1.3.6 Ischemic Heart Disease
1.4 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue 2019-2030
1.4.2 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales 2019-2030
1.4.3 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Therapeutic Proteins for Cardiovascular Disorders Treatment Market Competition by Manufacturers
2.1 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Average Price by Manufacturers (2019-2024)
2.4 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Therapeutic Proteins for Cardiovascular Disorders Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Therapeutic Proteins for Cardiovascular Disorders Treatment, Product Type & Application
2.7 Therapeutic Proteins for Cardiovascular Disorders Treatment Market Competitive Situation and Trends
2.7.1 Therapeutic Proteins for Cardiovascular Disorders Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Therapeutic Proteins for Cardiovascular Disorders Treatment Players Market Share by Revenue
2.7.3 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Therapeutic Proteins for Cardiovascular Disorders Treatment Retrospective Market Scenario by Region
3.1 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Region: 2019-2030
3.2.1 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Region: 2019-2024
3.2.2 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Region: 2025-2030
3.3 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Region: 2019-2030
3.3.1 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Region: 2019-2024
3.3.2 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Region: 2025-2030
3.4 North America Therapeutic Proteins for Cardiovascular Disorders Treatment Market Facts & Figures by Country
3.4.1 North America Therapeutic Proteins for Cardiovascular Disorders Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2019-2030)
3.4.3 North America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Market Facts & Figures by Country
3.5.1 Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2019-2030)
3.5.3 Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2019-2030)
3.6.3 Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Market Facts & Figures by Country
3.7.1 Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2019-2030)
3.7.3 Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Type (2019-2030)
4.1.1 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Type (2019-2024)
4.1.2 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Type (2025-2030)
4.1.3 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Type (2019-2030)
4.2 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Type (2019-2030)
4.2.1 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Type (2019-2024)
4.2.2 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Type (2025-2030)
4.2.3 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Application (2019-2030)
5.1.1 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Application (2019-2024)
5.1.2 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Application (2025-2030)
5.1.3 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Application (2019-2030)
5.2 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Application (2019-2030)
5.2.1 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Application (2019-2024)
5.2.2 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Application (2025-2030)
5.2.3 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Therapeutic Proteins for Cardiovascular Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Therapeutic Proteins for Cardiovascular Disorders Treatment Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Eli Lilly & Company
6.2.1 Eli Lilly & Company Corporation Information
6.2.2 Eli Lilly & Company Description and Business Overview
6.2.3 Eli Lilly & Company Therapeutic Proteins for Cardiovascular Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly & Company Therapeutic Proteins for Cardiovascular Disorders Treatment Product Portfolio
6.2.5 Eli Lilly & Company Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Therapeutic Proteins for Cardiovascular Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Therapeutic Proteins for Cardiovascular Disorders Treatment Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Therapeutic Proteins for Cardiovascular Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Therapeutic Proteins for Cardiovascular Disorders Treatment Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Bristol Myers Squibb
6.5.1 Bristol Myers Squibb Corporation Information
6.5.2 Bristol Myers Squibb Description and Business Overview
6.5.3 Bristol Myers Squibb Therapeutic Proteins for Cardiovascular Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bristol Myers Squibb Therapeutic Proteins for Cardiovascular Disorders Treatment Product Portfolio
6.5.5 Bristol Myers Squibb Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Therapeutic Proteins for Cardiovascular Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Therapeutic Proteins for Cardiovascular Disorders Treatment Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Therapeutic Proteins for Cardiovascular Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Therapeutic Proteins for Cardiovascular Disorders Treatment Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Amgen
6.8.1 Amgen Corporation Information
6.8.2 Amgen Description and Business Overview
6.8.3 Amgen Therapeutic Proteins for Cardiovascular Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Amgen Therapeutic Proteins for Cardiovascular Disorders Treatment Product Portfolio
6.8.5 Amgen Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Therapeutic Proteins for Cardiovascular Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Novartis Therapeutic Proteins for Cardiovascular Disorders Treatment Product Portfolio
6.9.5 Novartis Recent Developments/Updates
6.10 Siemens Healthineers
6.10.1 Siemens Healthineers Corporation Information
6.10.2 Siemens Healthineers Description and Business Overview
6.10.3 Siemens Healthineers Therapeutic Proteins for Cardiovascular Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Siemens Healthineers Therapeutic Proteins for Cardiovascular Disorders Treatment Product Portfolio
6.10.5 Siemens Healthineers Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic Proteins for Cardiovascular Disorders Treatment Industry Chain Analysis
7.2 Therapeutic Proteins for Cardiovascular Disorders Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic Proteins for Cardiovascular Disorders Treatment Production Mode & Process
7.4 Therapeutic Proteins for Cardiovascular Disorders Treatment Sales and Marketing
7.4.1 Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Channels
7.4.2 Therapeutic Proteins for Cardiovascular Disorders Treatment Distributors
7.5 Therapeutic Proteins for Cardiovascular Disorders Treatment Customers
8 Therapeutic Proteins for Cardiovascular Disorders Treatment Market Dynamics
8.1 Therapeutic Proteins for Cardiovascular Disorders Treatment Industry Trends
8.2 Therapeutic Proteins for Cardiovascular Disorders Treatment Market Drivers
8.3 Therapeutic Proteins for Cardiovascular Disorders Treatment Market Challenges
8.4 Therapeutic Proteins for Cardiovascular Disorders Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Competitive Situation by Manufacturers in 2023
Table 4. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Therapeutic Proteins for Cardiovascular Disorders Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Therapeutic Proteins for Cardiovascular Disorders Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Therapeutic Proteins for Cardiovascular Disorders Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Therapeutic Proteins for Cardiovascular Disorders Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Therapeutic Proteins for Cardiovascular Disorders Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Therapeutic Proteins for Cardiovascular Disorders Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Proteins for Cardiovascular Disorders Treatment as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Region (2019-2024) & (K Units)
Table 18. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Region (2019-2024)
Table 19. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Region (2025-2030) & (K Units)
Table 20. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Region (2025-2030)
Table 21. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Region (2019-2024)
Table 23. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Region (2025-2030)
Table 25. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2019-2024) & (K Units)
Table 27. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2025-2030) & (K Units)
Table 28. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2019-2024) & (K Units)
Table 32. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2025-2030) & (K Units)
Table 33. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units) by Type (2019-2024)
Table 51. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units) by Type (2025-2030)
Table 52. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Type (2019-2024)
Table 53. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Type (2025-2030)
Table 54. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Type (2019-2024)
Table 57. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Type (2025-2030)
Table 58. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price (USD/Unit) by Type (2019-2024)
Table 59. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price (USD/Unit) by Type (2025-2030)
Table 60. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units) by Application (2019-2024)
Table 61. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units) by Application (2025-2030)
Table 62. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Application (2019-2024)
Table 63. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Application (2025-2030)
Table 64. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Application (2019-2024)
Table 67. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Application (2025-2030)
Table 68. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price (USD/Unit) by Application (2019-2024)
Table 69. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price (USD/Unit) by Application (2025-2030)
Table 70. Johnson & Johnson Corporation Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Johnson & Johnson Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Eli Lilly & Company Corporation Information
Table 76. Eli Lilly & Company Description and Business Overview
Table 77. Eli Lilly & Company Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Eli Lilly & Company Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 79. Eli Lilly & Company Recent Developments/Updates
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Roche Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 84. Roche Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Bristol Myers Squibb Corporation Information
Table 91. Bristol Myers Squibb Description and Business Overview
Table 92. Bristol Myers Squibb Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Bristol Myers Squibb Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 94. Bristol Myers Squibb Recent Developments/Updates
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Sanofi Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 99. Sanofi Recent Developments/Updates
Table 100. Merck Corporation Information
Table 101. Merck Description and Business Overview
Table 102. Merck Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Merck Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 104. Merck Recent Developments/Updates
Table 105. Amgen Corporation Information
Table 106. Amgen Description and Business Overview
Table 107. Amgen Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Amgen Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 109. Amgen Recent Developments/Updates
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Novartis Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 114. Novartis Recent Developments/Updates
Table 115. Siemens Healthineers Corporation Information
Table 116. Siemens Healthineers Description and Business Overview
Table 117. Siemens Healthineers Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Siemens Healthineers Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 119. Siemens Healthineers Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Therapeutic Proteins for Cardiovascular Disorders Treatment Distributors List
Table 123. Therapeutic Proteins for Cardiovascular Disorders Treatment Customers List
Table 124. Therapeutic Proteins for Cardiovascular Disorders Treatment Market Trends
Table 125. Therapeutic Proteins for Cardiovascular Disorders Treatment Market Drivers
Table 126. Therapeutic Proteins for Cardiovascular Disorders Treatment Market Challenges
Table 127. Therapeutic Proteins for Cardiovascular Disorders Treatment Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Therapeutic Proteins for Cardiovascular Disorders Treatment
Figure 2. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Share by Type in 2023 & 2030
Figure 4. Monoclonal Antibodies Proteins Product Picture
Figure 5. Peptides Proteins Product Picture
Figure 6. Peptide Fragments Proteins Product Picture
Figure 7. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Share by Application in 2023 & 2030
Figure 9. Heart Failure
Figure 10. Myocardial Infarction
Figure 11. Arrhythmias
Figure 12. Coronary Artery Disease
Figure 13. Ischemic Heart Disease
Figure 14. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Size (2019-2030) & (US$ Million)
Figure 16. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (2019-2030) & (K Units)
Figure 17. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Average Price (USD/Unit) & (2019-2030)
Figure 18. Therapeutic Proteins for Cardiovascular Disorders Treatment Report Years Considered
Figure 19. Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Share by Manufacturers in 2023
Figure 20. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Therapeutic Proteins for Cardiovascular Disorders Treatment Players: Market Share by Revenue in 2023
Figure 22. Therapeutic Proteins for Cardiovascular Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Country (2019-2030)
Figure 25. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Country (2019-2030)
Figure 29. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Country (2019-2030)
Figure 30. Germany Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Region (2019-2030)
Figure 37. China Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Country (2019-2030)
Figure 48. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Therapeutic Proteins for Cardiovascular Disorders Treatment by Type (2019-2030)
Figure 58. Global Revenue Market Share of Therapeutic Proteins for Cardiovascular Disorders Treatment by Type (2019-2030)
Figure 59. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price (USD/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Therapeutic Proteins for Cardiovascular Disorders Treatment by Application (2019-2030)
Figure 61. Global Revenue Market Share of Therapeutic Proteins for Cardiovascular Disorders Treatment by Application (2019-2030)
Figure 62. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price (USD/Unit) by Application (2019-2030)
Figure 63. Therapeutic Proteins for Cardiovascular Disorders Treatment Value Chain
Figure 64. Therapeutic Proteins for Cardiovascular Disorders Treatment Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
